Availom
Also known as: AvailOm omega-3 lysine complex, Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) lysine complex, AvailOm
Overview
AvailOm is a proprietary omega-3 lysine complex developed by Evonik, which integrates eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with the amino acid L-lysine. It is synthesized from sustainable sources such as algae and fish oil, optimized to enhance the bioavailability of omega-3 fatty acids more effectively than traditional ethyl-ester formulations. AvailOm is primarily used to support cardiovascular, cognitive, and ocular health, especially in pregnant women, nursing mothers, and older adults. It stands out due to its high bioavailability, being up to five times more effective than conventional omega-3 supplements. The initial human studies for this product began in 2020, indicating a promising but still limited body of research.
Benefits
Evidence suggests that AvailOm significantly enhances plasma levels of EPA and DHA compared to standard omega-3 supplements, with a bioavailability reported to be five times higher. While health outcomes directly linked to AvailOm are insufficiently documented in peer-reviewed literature, potential benefits include improved cardiovascular health and cognitive function—primarily inferred from general omega-3 research. Specific populations, particularly pregnant women and older adults, may derive greater benefits due to the higher absorption rate. Clinical studies emphasize its enhanced bioavailability, but further research is necessary to establish definitive health benefits.
How it works
AvailOm operates by forming a lysine complex with EPA and DHA that allows these omega-3 fatty acids to be absorbed without the need for bile salts or pancreatic lipases, thereby enhancing their bioavailability. This mechanism enables more efficient distribution of omega-3s, which play crucial roles in supporting cardiovascular, brain, and eye health through increased availability in systemic circulation.
Side effects
AvailOm is generally considered safe for consumption, yet comprehensive side effect data remain limited. Common adverse effects associated with omega-3 supplementation, such as gastrointestinal disturbances, may occur but are not well documented for AvailOm specifically. Rare side effects are not reported. Caution is advisable for individuals on anticoagulant medications due to potential interactions, although specific studies on AvailOm's interactions are lacking. Pregnant women and individuals with bleeding disorders should consult healthcare providers prior to use.
Dosage
While specific dosing guidelines for AvailOm are not well-documented in peer-reviewed literature, it typically adheres to general omega-3 dosing ranges. The product can be taken with or without food, taking advantage of its high bioavailability. Absorption may be further enhanced by using the supplement in powder form, suitable for application in tablets or capsules. No established maximum safe dose exists, indicating that further research is needed to determine optimal dosing strategies.
FAQs
How does AvailOm compare to traditional omega-3 supplements in terms of efficacy and safety?
AvailOm offers higher bioavailability than traditional omega-3 supplements, improving absorption without the need for emulsification. While generally safe, it’s essential to consult a healthcare provider, especially in the presence of health conditions.
Can AvailOm be taken with or without food?
Yes, AvailOm can be taken at any time, with or without food, thanks to its superior bioavailability.
What results can I expect from using AvailOm?
Users may experience improved omega-3 absorption, potentially leading to associated health benefits such as enhanced cardiovascular and cognitive function thought to arise from omega-3 supplementation.
Are there any common misconceptions about omega-3 supplements?
A common misconception is that all omega-3 supplements offer similar bioavailability. AvailOm significantly differs due to its specialized formulation.
Research Sources
- https://healthcare.evonik.com/en/first-in-human-study-confirms-evoniks-availom-omega-3-lysine-complex-has-significantly-higher-bioava-151769.html – This study confirms that AvailOm exhibits five times higher bioavailability compared to traditional ethyl-ester omega-3 formulations, based on its lysine complexation, although limitations include a small sample size and a focus on bioavailability rather than broader health outcomes.
- https://pubmed.ncbi.nlm.nih.gov/32293681/ – This systematic review examines the impact of omega-3 supplementation on muscle strength, primarily in older adults, indicating improvements but noting variability among studies, which may affect applicability to AvailOm.
- https://www.evonik.com/en/applications/application_1659055/availom-omega-3-powder.html – This source outlines the properties of AvailOm and its formulation, emphasizing its composition and potential applications in health, although lacking extensive clinical evidence at this time.
- https://www.mdpi.com/2072-6643/14/11/2221 – A systematic review discussing the role of omega-3 fatty acids in cardiovascular disease prevention, detailing the potential benefits but highlighting mixed results and inconsistency across studies.
- https://pubmed.ncbi.nlm.nih.gov/36103100/ – This meta-analysis examines the cardiovascular benefits of omega-3 fatty acids, presenting evidence of their effectiveness in reducing major cardiovascular events but noting that results may vary based on study designs.
